Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 132,700 shares, an increase of 15.8% from the July 15th total of 114,600 shares. Based on an average trading volume of 949,800 shares, the days-to-cover ratio is currently 0.1 days. Currently, 6.0% of the shares of the stock are sold short.
Altamira Therapeutics Trading Down 5.2 %
Shares of CYTO traded down $0.05 during mid-day trading on Friday, reaching $0.96. The company’s stock had a trading volume of 1,044,182 shares, compared to its average volume of 1,018,854. Altamira Therapeutics has a 52 week low of $0.79 and a 52 week high of $17.20. The company’s fifty day moving average price is $1.16 and its two-hundred day moving average price is $1.54.
About Altamira Therapeutics
Featured Articles
- Five stocks we like better than Altamira Therapeutics
- What Are Dividend Champions? How to Invest in the Champions
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Transportation Stocks Investing
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Altamira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altamira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.